Senores Pharmaceuticals Ltd. (NSE: SENORES) has emerged as a notable small-cap stock in India’s pharmaceutical space. Currently trading at ₹670.00, it has attracted attention due to strong revenue growth and recent price action. Investors are now watching closely:Can Senores hit ₹700 or even ₹825 in 2025? Latest Market Overview (as of July 25, 2025) Current…
Senores Pharmaceuticals Ltd is a growing pharmaceutical company focused on developing and delivering high-quality generic medicines and specialized formulations. Known for its innovation and customer-centric approach, the company caters to both domestic and international markets, with a strong presence in regulated and emerging regions. Senores Pharmaceuticals emphasizes research and development to bring affordable and effective…
Senores Pharmaceuticals Share Price Target 2025:- Senores Pharmaceuticals Ltd., established in 2017 and headquartered in Ahmedabad, India, is a rapidly growing pharmaceutical company specializing in the development and manufacturing of complex generic medications. With a global presence spanning 49 countries, including the USA, Canada, and various emerging markets, Senores focuses on producing high-quality, affordable medicines…